Pharma & Healthcare Comms & Reputation Conference 2026
18 November 2026
De Vere Grand Connaught Rooms, London, United Kingdom
The 7th annual Pharma & Healthcare Comms & Reputation Conference is a one-day, industry-led conference and networking exhibition for in-house pharma and healthcare communications and reputation professionals, produced by Global Insight Conferences. The programme covers AI in strategic communications, patient partnerships, disease awareness, geopolitics, social media, stakeholder ecosystems, misinformation and trust, measuring impact, compliance and reputation management, with panels, keynotes, delegate discussions and peer-to-peer discussion zones.
20 sessions · 27 speakers
Organiser (1)
Sponsors (5)
Inizio Evoke · AG Impact · Spectrum Science · We. Communications · Langland
Speakers (27)
- Alessandra Fonseca Global External Communication Director, Kedrion Biopharma
- Katie Vickers Social Media & Digital Communications Manager, AbbVie
- Krysia Sommers Head of Strategic and Executive Communications, Bayer
- Marco Gerometta Communications Director – Global Clinical Operations, R&D, GSK
- Megan Ardis Senior Brand Risk Intelligence Analyst and Subject Matter Expert, Resolver, a Kroll Business
- Robert Ede Senior Director and Head of Corporate Affairs, Lilly
- Karen Borrer Head of Communications, UCB
- Marina Moustaka Director, International Medical Communications, Abbvie
- Rachel James-Owens Vice President Corporate Communications and Media Relations, Zealand Pharma
- Alina Jenkins Head of Communications & Training, Body Talk
- Alvaro Ingles Prieto Senior Manager Innovation Unit Communications, Corporate Affairs, Boehringer Ingleheim
- Emma Robertson Associate Director, Social Media, Langland
- Laura Chamley Senior Director Public Affairs, Gilead Sciences
- Mark Grossien Head of Strategic Communications, Sandoz
- Chiara Antoniucci Global External & Internal Communication Director, Angelini Pharma
- Claire Murray Executive Director, Client Services, Spectrum Science
- Diana Trojanus Communications Director, EMEA Region, Merz Aesthetics
- Eoin Weldon Head of EMEA Communications, Merck Life Sciences
- Gabor Purman Patient Advocacy Director, Kyowa Kirin
- Jérôme Dévé Director of External Communications, Pfizer
- Katherine Jordan Senior Director for Corporate Affairs, Novo Nordisk
- Lisa Timothy Head of Public Affairs & Patient Advocacy, Takeda
- Lucie Sabikova Head of Communications MCO Eastern Europe, Takeda
- Luke Willats Head of Global Communications & Strategic Affairs, Merz Therapeutics
- Marie-Louise Møller Lange Head of IO RA Policy & Advocacy, Novo Nordisk
- Pia Beltrao Hansen Senior Director, Head of Commercial Communications, Ascendis Pharma
- Rene Rust Head of Corporate Communications and Government Affairs, Almirall
Agenda
- GIC Welcome & Morning Chair’s Opening Remarks 18 November 2026
- Strategic Leveraging Of AI In Communications 18 November 2026
- Effective Patient Partnerships 18 November 2026
- Disease Awareness 18 November 2026
- Signals in the Noise: An Intelligence-Led Framework for Partnership Vetting 18 November 2026
- If Misinformation Can Scale on Social, Why Can't Science? 18 November 2026
- Geopolitics: Agility in Uncertainty 18 November 2026
- Why Pharma Needs To Start Treating Social Media As Social Media 18 November 2026
- Narrative Distortion in Health 18 November 2026
- Peer To Peer Discussion Zones: B) Strategic Role of Comms 18 November 2026
- Peer To Peer Discussion Zones: A) AI as a Tool in Comms 18 November 2026
- Afternoon Co-Chairs’ Opening Remarks 18 November 2026
- The Trust Gap: Why Expertise Isn’t Enough 18 November 2026
- Evolving Stakeholder Ecosystems 18 November 2026
- Misinformation, Trust & Credibility 18 November 2026
- Building Reputation – ABPI’s Value of Industry Campaign 18 November 2026
- Measuring Impact in Pharma Comms 18 November 2026
- Reputation Management 18 November 2026
- Compliance without Constraint 18 November 2026
- Health Equity 18 November 2026